ESC 2019 - PACE-CME

17-32 of 43

Almost significant effects on CV outcomes with ARNI in HFpEF
Almost significant effects on CV outcomes with ARNI in HFpEF
ESC 2019
Almost significant effects on CV outcomes with ARNI in HFpEF
Prof. Dirk Jan van Veldhuisen, MD
- Prof. Dirk Jan van Veldhuisen, MD
LDL-c lowering with twice-a-year injection of siRNA against PCSK9: The ORION-11 trial
LDL-c lowering with twice-a-year injection of siRNA against PCSK9: The ORION-11 trial
ESC 2019
LDL-c lowering with twice-a-year injection of siRNA against PCSK9: The ORION-11 trial
Prof. John Kastelein, MD
- Prof. John Kastelein, MD
The 2019 ESC/EAS Dyslipidemia Guidelines from the point of view of the European Atherosclerosis Society
The 2019 ESC/EAS Dyslipidemia Guidelines from the point of view of the European Atherosclerosis Society
ESC 2019
The 2019 ESC/EAS Dyslipidemia Guidelines from the point of view of the European Atherosclerosis Society
Prof. Alberico Catapano, PhD
- Prof. Alberico Catapano, PhD
Long-term treatment with dual antiplatelet therapy in patients with diabetes and stable CAD
Long-term treatment with dual antiplatelet therapy in patients with diabetes and stable CAD
ESC 2019
Long-term treatment with dual antiplatelet therapy in patients with diabetes and stable CAD
Prof. Ph. Gabriel Steg, MD
- Prof. Ph. Gabriel Steg, MD
Large community-based studies stress the impact of preventive measures
Large community-based studies stress the impact of preventive measures
ESC 2019
Large community-based studies stress the impact of preventive measures
Prof. Salim Yusuf
- Prof. Salim Yusuf
Rationale for the lower LDL-c targets in the 2019 ESC/EAS Dyslipidemia Guidelines
Rationale for the lower LDL-c targets in the 2019 ESC/EAS Dyslipidemia Guidelines
ESC 2019
Rationale for the lower LDL-c targets in the 2019 ESC/EAS Dyslipidemia Guidelines
Prof. François Mach, MD
- Prof. François Mach, MD
Importance of continuous use of secondary prevention therapy after CABG
Importance of continuous use of secondary prevention therapy after CABG
ESC 2019
Importance of continuous use of secondary prevention therapy after CABG
Reduction in bleeding with genotype-guided strategy for choice of P2Y12i in STEMI patients
Reduction in bleeding with genotype-guided strategy for choice of P2Y12i in STEMI patients
ESC 2019
Reduction in bleeding with genotype-guided strategy for choice of P2Y12i in STEMI patients
A one-hour hs-troponin protocol in ACS suspected patients resulted in more rapid discharge
A one-hour hs-troponin protocol in ACS suspected patients resulted in more rapid discharge
ESC 2019
A one-hour hs-troponin protocol in ACS suspected patients resulted in more rapid discharge
Prof. Derek Chew
- Prof. Derek Chew
All-cause mortality benefit with ICD use in STEMI patients treated with primary PCI
All-cause mortality benefit with ICD use in STEMI patients treated with primary PCI
ESC 2019
All-cause mortality benefit with ICD use in STEMI patients treated with primary PCI
10-year outcomes with CABG versus PCI in patients with three-vessel disease or left main CAD
10-year outcomes with CABG versus PCI in patients with three-vessel disease or left main CAD
ESC 2019
10-year outcomes with CABG versus PCI in patients with three-vessel disease or left main CAD
The diabetes challenge for cardiologists: The key things to understand
The diabetes challenge for cardiologists: The key things to understand
ESC 2019
The diabetes challenge for cardiologists: The key things to understand
Prof Naveed Sattar, MD
- Prof Naveed Sattar, MD
Clear results with NOAC monotherapy in patients with CAD and AF
Clear results with NOAC monotherapy in patients with CAD and AF
ESC 2019
Clear results with NOAC monotherapy in patients with CAD and AF
Prof. Freek Verheugt
- Prof. Freek Verheugt
Community-wide salt restriction reduces blood pressure and incidence of hypertension
Community-wide salt restriction reduces blood pressure and incidence of hypertension
ESC 2019
Community-wide salt restriction reduces blood pressure and incidence of hypertension
Prof. Jaime Miranda
- Prof. Jaime Miranda
Early and sustained vasodilation strategy fails to improve outcomes in acute HF
Early and sustained vasodilation strategy fails to improve outcomes in acute HF
ESC 2019
Early and sustained vasodilation strategy fails to improve outcomes in acute HF
Prof. Christian Müller
- Prof. Christian Müller
Primary PCI is the best strategy for STEMI patients compared to fibrinolysis
Primary PCI is the best strategy for STEMI patients compared to fibrinolysis
ESC 2019
Primary PCI is the best strategy for STEMI patients compared to fibrinolysis
Michael Maeng, MD
- Michael Maeng, MD

2/3